Tag

Xbb15

All articles tagged with #xbb15

health2 years ago•3 min saved

Emergence of EU.1.1 COVID Variant in Multiple US States

The CDC is now tracking the EU.1.1 variant, a descendant of the XBB.1.5 variant, which is estimated to account for 1.7% of U.S. COVID-19 cases nationwide and potentially up to 8.7% in certain regions. It is unclear if EU.1.1 will cause new or different symptoms. Most variants in the U.S. belong to the XBB family, with XBB.1.5 being the largest at 27% of infections. COVID-19 hospitalizations and deaths in Utah have slowed, and the FDA has recommended revising vaccines to target the XBB.1.5 variant. Moderna has submitted its revised vaccine for emergency use authorization, which is expected to provide protection against related variants as well.

via CBS News|

#cdc #covid-19-variants #eu11

health2 years ago•1 min saved

FDA Approves Updated COVID-19 Vaccines Targeting Omicron and XBB Strains.

The FDA has approved the next round of COVID-19 vaccines targeting the XBB.1.5 strain of the Omicron variant. The three U.S. companies that make COVID-19 shots have geared up to make the formula change, with Pfizer saying it could have some doses ready as early as next month. The CDC will eventually decide whether to recommend the shot for nearly all Americans or just for certain high-risk groups.

via Fox News|

#covid-19-vaccines #fda #health

health2 years ago•1 min saved

FDA Advisers Recommend Updating Covid Shots for Omicron XBB.1.5 in Fall.

The FDA has recommended that Covid vaccine manufacturers develop single-strain shots for the fall that target the omicron subvariant XBB.1.5, which is the dominant strain of the virus in the US. The XBB.1.5 strain is a descendant of the omicron variant and is one of the most immune-evasive strains to date. Pfizer, Moderna, and Novavax have already been developing updated versions of their shots that target XBB.1.5, with Pfizer saying it will be able to deliver a monovalent shot targeting XBB.1.5 by July. The updated vaccines could be available to the public around September.

via CNBC|

#covid-vaccine #fda #health